Asthma Clinical Trials in Kansas City, Kansas

7 studies are recruiting for asthma in Kansas City, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

   The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of a…

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   Research Site, Kansas City, Kansas

   Locations

   150 in total

   Run by

   AstraZeneca

   See if you can join NCT06307665 on ClinicalTrials.gov

2. ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

   This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroids (ICS) and long-acting beta₂-agonists (LABA). Participants w…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Enveda Investigative Site, Kansas City, Kansas

   Locations

   18 in total

   Run by

   Enveda Therapeutics

   See if you can join NCT07301255 on ClinicalTrials.gov

3. Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

   This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Research Site, Kansas City, Kansas

   Locations

   221 in total

   Run by

   AstraZeneca

   See if you can join NCT06932263 on ClinicalTrials.gov

4. Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

   Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmat…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   GSK Investigational Site, Kansas City, Kansas

   Locations

   50 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT06979323 on ClinicalTrials.gov

5. Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

   The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.

   Stage

   Phase 1

   Ages

   3 and older

   Site

   University of Kansas Medical Center, Kansas City, Kansas

   Run by

   Mario Castro, MD, MPH

   See if you can join NCT04624490 on ClinicalTrials.gov

6. A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

   The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning o…

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   University of Kansas Medical Center, Kansas City, Kansas

   Locations

   132 in total

   Run by

   Pfizer

   See if you can join NCT06977581 on ClinicalTrials.gov

7. Individualizing Treatment for Asthma in Primary Care (Full Study)

   While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long…

   Stage

   Phase 4

   Ages

   13 to 75

   Site

   University of Kansas, Kansas City, Kansas

   Locations

   13 in total

   Run by

   DARTNet Institute

   See if you can join NCT07052942 on ClinicalTrials.gov